The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

NCT03294135 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Virus Diseases

Interventions

BIOLOGICAL: Encepur Adults

Sponsor

GlaxoSmithKline